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Background and Purpose  The incidence of ischemic stroke (IS) in young adults is increas-
ing, and the associated large socioeconomic impact makes understanding IS in young adults 
important. We investigated the causes of and risk factors for IS in young adults, and their impact 
on outcomes.
Methods  The Stroke in Korean Young Adults (SKY) study is a standardized multicenter pro-
spective study involving eight medical centers of the Republic of Korea. First-ever IS patients 
aged 18 years to 44 years were prospectively included in this study within 7 days of stroke onset. 
Their outcomes at 3 months were analyzed.
Results  This study enrolled 270 patients from April 2014 to December 2018, most (67.8%) 
of whom were male. About 41.5% of the patients had one or more vascular risk factors from 
among hypertension, diabetes mellitus, and dyslipidemia. However, only half of them had re-
ceived regular treatment. Arterial dissection was more common in males, and systemic lupus 
erythematosus (SLE) and Moyamoya disease were more common in females. The outcome 
was favorable (modified Rankin Scale score of 0 or 1) in 81.9% of the patients at 3 months af-
ter stroke onset. More severe initial symptoms, higher initial glucose level, and SLE as a co-
morbidity were associated with unfavorable outcomes.
Conclusions  Young adult IS patients in Korea exhibit low awareness and poor management of 
their risk factors. Although the short-term outcome was relatively favorable in those patients, 
having SLE was associated with unfavorable outcomes. More attention needs to be paid for im-
proving awareness and controlling risk factors in this population.
Key Words   ischemic stroke, young adults, outcome, systemic lupus erythematosus.
Causes, Risk Factors, and Clinical Outcomes of Stroke 
in Korean Young Adults: Systemic Lupus Erythematosus is 
Associated with Unfavorable Outcomes
INTRODUCTION
The incidence of ischemic stroke (IS) in young adults is increasing substantially world-
wide.1,2 Since young adults have long lifespans ahead of them and are productive members 
of the labor force, knowledge about IS in young adults deserves more attention.2 Howev-
er, investigating the causes of and risk factors for stroke in young adults is often challeng-
ing. Current guidelines provide limited information on the clinical management of stroke 
in young adults.3 In addition, most studies involving young stroke victims have had retro-
spective designs and been limited by missing data, nonstandardized evaluations, and high 
dropout rates during follow-up.
 The prevalence of traditional vascular risk factors is increasing in young adult patients 
with IS, and their origins differ from those of older adults.1 IS in young adults is associated 
with arterial dissection, Moyamoya disease (MMD), primary and secondary central ner-
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vous system vasculitis, antiphospholipid syndrome (APS), 
reversible cerebral vasoconstriction syndrome (RCVS), ce-
rebral venous thrombosis (CVT), and genetic diseases such 
as cerebral autosomal dominant arteriopathy with subcorti-
cal infarcts and leukoencephalopathy (CADASIL) and Fabry 
disease. However, the causes of 15–35% of the strokes in 
young adults are still unidentified.4 In addition, the connec-
tion between these etiological factors and stroke outcomes 
remains unclear. 
The Stroke in Korean Young Adults (SKY) study aimed to 
evaluate the traditional and emerging risk factors for stroke in 
young adults. We also investigated the etiologies, treatments, 
and outcomes of stroke in these patients.
METHODS
Study design and diagnostic workup
The SKY study is a standardized multicenter prospective 
study performed in eight medical centers in the Republic of 
Korea. Details of the rationale and design of this study have 
been reported previously.5 From April 2014 to December 
2018, 270 patients with first-ever IS visited the Department of 
Neurology, and those aged 18 years to 44 years were consec-
utively enrolled as case subjects. We intended to include 470 
case subjects and 470 age- and sex-matched community con-
trol subjects.5 However, we stopped adding patients after en-
rolling 270 case subjects because an interim analysis of the 
association between job strain and IS produced somewhat 
positive results.
Demographic data were collected, and brain imaging, car-
diac evaluations, and laboratory studies were performed as 
described previously.5 For the cardiac evaluations, all of the 
available patients underwent 24-hour Holter monitoring, 
transthoracic echocardiography, and transesophageal echo-
cardiography. We sought to identify well-supported risk fac-
tors and uncommon etiologies among the young patients 
with IS. In addition, the acute management and 3-month out-
comes of acute IS were investigated. The study was approved 
by the ethics committee at each participating center, and is reg-
istered at clinicaltrials.gov under the number NCT02682914.
Stroke classification, definition of other etiologies, 
and follow-up
The IS subtypes were classified according to the Trial of Org 
10172 in Acute Stroke Treatment (TOAST) criteria.6 The 
classification was reviewed independently by two neurolo-
gists, and a consensus approach was applied if there were 
discrepancies. Stroke in a patient with both high- and moder-
ate-risk cardiac sources of embolism and no other cause of 
stroke was considered a case of cardioembolic stroke.6 
Arterial dissection was diagnosed by angiography if there 
was a double lumen, intramural hematoma, nonatherosclerotic 
tapered, flame-shaped stenosis/occlusion or pearl-and-string 
sign, or a dissecting aneurysm at a nonbranching site.7 MMD 
was diagnosed if there was chronic, occlusive cerebrovascular 
disease with Moyamoya vessels.8 Systemic lupus erythemato-
sus (SLE) was diagnosed according to the classification crite-
ria of the Systematic Lupus International Collaborating Clinics 
group,9 and was regarded as the culprit etiology when an event 
was not assigned to a conventional stroke etiology. The up-
dated Sapporo classification criteria were used for APS.10 RCVS 
was characterized by thunderclap headaches and diffuse seg-
mental constriction of the cerebral arteries that resolved with-
in 3 months.11 If a thrombus in a venous sinus was detected 
by magnetic resonance or computed tomography venogra-
phy in clinically suspected patients, CVT was diagnosed.12 
Two patients died, and the remaining 268 of the 270 patients 
were followed up to 3 months in the outpatient clinic of each 
hospital. Modified Rankin Scale (mRS) scores were obtained 
at 3 months.
Statistical analysis
Mean±SD values were calculated for continuous variables, 
and numbers with percentages were calculated for discrete 
variables. We used Student’s t-tests, the chi-square test, and the 
Mann-Whitney U test to evaluate differences between groups. 
Correlations between clinical characteristics and a favorable 
outcome (mRS score of 0 or 1) were measured by logistic re-
gression analysis, adjusting covariates for which p<0.2 in the 
univariate analysis. The adjusted variables were the initial 
National Institutes of Health Stroke Scale (NIHSS) score, a pat-
ent foramen ovale (PFO), SLE, RCVS, white-blood-cell count, 
and blood urea nitrogen, fasting glucose, and fibrinogen levels. 
RESULTS
Demographic data and risk factors
The 270 enrolled patients were aged 37.1±6.3 years, of which 
183 were males. The median NIHSS score was 2 [interquar-
tile range (IQR)=0–4] at admission and 1 (IQR=0–2) at dis-
charge. At discharge, 30.0% of the patients had hyperten-
sion, 12.2% had diabetes mellitus (DM), and 17.4% had 
dyslipidemia. However, the risk factors had been known and 
treated regularly for only half of the patients. In addition, 
47.8% of them were current smokers and 17.8% were obese 
[body mass index (BMI) ≥30.0 kg/m2].
The baseline characteristics including demographic data 
and risk factors are presented in Table 1. The males were sig-
nificantly older than the females (mean age=37.9 years vs. 35.4 
years, p=0.002) and they had significantly higher rates of hy-
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pertension (p=0.021) and current smoking (p<0.001), and a 
higher BMI (p<0.001). There were no other sex-related dif-
ferences. 
Subtypes of ischemic stroke and other determined 
etiologies 
The IS subtypes according to the TOAST classification are 
Table 1. Baseline characteristics including classification of ischemic stroke in the study patients
Total (n=270) Males (n=183) Females (n=87) p
Demographics
Age, years 37.1±6.3 37.9±5.8 35.4±7.0 0.002
Risk factor
Hypertension 81 (30.0) 63 (34.4) 18 (20.7) 0.021
Diabetes mellitus 33 (12.2) 27(14.8) 6 (6.9) 0.065
Dyslipidemia 47 (17.4) 35 (19.1) 12 (13.8) 0.280
Current smoking 129 (47.8) 110 (60.1) 19 (21.8) <0.001
Atrial fibrillation 6 (2.2) 2 (1.1) 4 (4.6) 0.087
Coronary artery disease 4 (1.5) 3 (1.6) 1 (1.1) 1.000
PFO 23 (8.5) 15 (8.2) 8 (9.2) 0.784
Chronic kidney disease 11 (4.1) 5 (2.7) 6 (6.9) 0.183
BMI, kg/m2 25.5±5.0 26.3±4.4 23.8±5.7 <0.001
Obesity 48 (17.8) 34 (18.6) 14 (16.1) 0.617
Medication history
Antihypertensives 46 (17.0) 35 (19.1) 11 (12.6) 0.186
Antidiabetes 16 (5.9) 10 (5.5) 6 (6.9) 0.641
Statins 30 (11.1) 22 (12.0) 8 (9.2) 0.490
Stroke subtype 0.065
Large-artery disease 42 (15.6) 35 (19.1) 7 (8.0)
Small-vessel occlusion 48 (17.8) 37 (20.2) 11 (12.6)
Cardioembolism* 34 (12.6) 20 (10.9) 14 (16.1)
Undetermined, two or more 2 (0.7) 2 (1.1) 0 (0.0)
Undetermined, negative 55 (20.4) 33 (18.0) 22 (25.3)
Undetermined, incomplete 1 (0.4) 1 (0.5) 0 (0.0)
Other determined 88 (32.6) 55 (30.1) 31 (35.6)
Dissection 38 (14.1) 30 (16.4) 8 (9.2) 0.112
SLE† 10 (3.7) 1 (0.5) 9 (10.3) <0.001
Moyamoya disease 10 (3.7) 2 (1.1) 8 (9.2) 0.002
APS without SLE 8 (3.0) 7 (3.8) 1 (1.1) 0.443
Cerebral venous thrombosis 6 (2.2) 3 (1.6) 3 (3.4) 0.391
RCVS 4 (1.5) 3 (1.6) 1 (1.1) 1.000
CADASIL 2 (0.7) 2 (1.1) 0 (0.0) 1.000
Primary angiitis of CNS 2 (0.7) 2 (1.1) 0 (0.0) 1.000
Thrombosed aneurysm 2 (0.7) 2 (1.1) 0 (0.0) 1.000
Others‡ 6 (2.2) 3 (1.6) 3 (1.6) 1.000
Lesion location 0.469
Anterior circulation 147 (54) 95 (52) 52 (60)
Posterior circulation 115 (43) 82 (45) 33 (38)
Combined 8 (3) 6 (3) 2 (2)
Initial NIHSS score 2 (0–4) 2 (1–4) 2 (0–4) 0.908
Data are mean±SD, median (interquartile range), or n (%) values. Obesity was defined as BMI ≥30.0 kg/m2. Pearson’s chi-square test, Student’s t-test, 
Fisher’s exact test, and the Mann-Whitney U test were used as appropriate.
*One patient had both SLE and dilated cardiomyopathy, †If both SLE and APS were present, SLE was considered the etiology, ‡Others include radiation-
induced angiopathy, hyperhomocysteinemia, Fabry disease, aortic angiosarcoma, hypereosinophilic syndrome, and calcium pyrophosphate deposition.
APS: antiphospholipid syndrome, BMI: body mass index, CADASIL: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoen-
cephalopathy, CNS: central nervous system, NIHSS: National Institutes of Health Stroke Scale, PFO: patent foramen ovale, RCVS: reversible cerebral
vasoconstriction syndrome, SLE: systemic lupus erythematosus.
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listed in Table 1. Patients were classified as follows: large ar-
tery disease in 42 patients (15.6%), small vessel occlusion in 
48 (17.8%), cardioembolism in 34 (12.6%), other determined 
etiologies in 88 (32.6%), and undetermined etiology in 58 
(21.5%). Among the 34 patients with cardioembolic stroke, 6 
(17.6%) had atrial fibrillation (3 lone and 3 other than lone), 
18 (52.9%) had PFO, 2 (5.9%) had recent myocardial infarc-
tion, 2 (5.9%) had a mechanical prosthetic valve, 2 (5.9%) had 
mitral stenosis, 2 (5.9%) had myxoma, 1 (2.9%) had dilated 
cardiomyopathy, and 1 (2.9%) had infective endocarditis. 
The 88 patients with other determined etiologies comprised 
38 (14.1%) with arterial dissection, 11 (4.4%) with SLE, 10 
(3.7%) with MMD, 8 (3.0%) with primary APS without SLE, 
6 (2.2%) with CVT, 4 (1.5%) with RCVS, and 2 each (0.7%) 
with CADASIL, primary angiitis, and thrombosed aneurysm 
(Table 1). One patient with both SLE and dilated cardiomy-
opathy was included in SLE, but the cause was classified as 
cardioembolism. Males had a higher rate of arterial dissection 
and females a higher rate of SLE and MDD. Factor V Leiden 
was not identified in any patient.
Clinical outcomes and factors associated with 
unfavorable outcomes
The characteristics of patients according to favorable and un-
favorable outcomes at 3 months are presented in Table 2. Pa-
tients with an unfavorable outcome had a higher initial NI-
HSS score, SLE and higher white-blood-cell count. Intravenous 
thrombolysis (IVT) and/or intra-arterial thrombectomy (IAT) 
were applied to 24 patients (8.9%). Early neurological im-
provement (NIHSS score of 0 to 1 or improvement of ≥8 at 
discharge) occurred in 56% of those who received IVT alone 
and in 73% of those who received IAT with or without IVT. 
However, the proportion of patients receiving IAT or IVT did 
not differ between the two subgroups (Table 2).
During the 3-month follow-up there were five (1.8%) stroke 
events (four IS and one hemorrhagic stroke), and two (0.7%) 
patients died. There were no myocardial infarction events, 
and post-stroke seizure occurred in four (1.4%) patients. At 3 
months after stroke onset, 81.9% of the patients (213 of 260) 
had a favorable outcome (mRS score of 0 or 1), while more 
than 90.4% of them had an mRS score of ≤2 (Fig. 1). After 
adjusting for potential confounding variables, higher initial 
NIHSS score, higher initial glucose level, and having SLE were 
associated with an unfavorable outcome (Table 3).
DISCUSSION
This study found relatively favorable outcomes in young-adult 
IS patients. More than 80% and 90% of the included patients 
had mRS scores of ≤1 and ≤2, respectively, at 3 months after 
stroke onset. This proportion was much higher than in patients 
of all ages, 50% of whom reportedly had an mRS score of 0 
or 1 at 3 months.13 An unfavorable outcome was associated 
with higher initial NIHSS score, higher initial glucose level, 
and SLE as comorbidity. IS was more common in males than 
females (67.8% vs 32.2%). About 41.5% of the patients had 
one or more of the vascular risk factors among hypertension, 
DM, and dyslipidemia, but only half of them had been aware 
of their risk factors and received regular treatment. We con-
sider that neglect of these risk factors could be an important 
cause of IS in young patients. 
Poststroke mortality occurred in only two (0.7%) patients 
during the 3-month follow-up, and five (1.8%) patients suf-
fered recurrent stroke. These outcomes are more favorable 
than in previous reports. In a Swiss prospective study involv-
ing 624 IS patients, 61% and 85% had mRS scores of ≤1 and 
≤2, respectively.14 In a French study, mRS scores of ≤2 were 
present in 87% of 287 young adults with IS after 3 years of 
follow-up.15 The higher rate of favorable outcomes in our 
study may have been due to improved stroke treatments in-
cluding the use of mechanical thrombectomy. Fourteen of the 
15 patients who received IAT showed recanalization more 
than Thrombolysis in Cerebral Infarction (TICI) grade 2b, 
and 11 patients showed early neurological improvement. The 
patients who benefited from IAT may have shifted from 
poor outcome patients to favorable-outcome patients. Thus, 
investigating the IAT outcomes of young IS patients would be 
useful.
Our detailed and standardized evaluation of the etiologies 
of stroke in young adults classified 31.9% of the patients as 
other determined etiologies. Arterial dissection was more 
common in males, and SLE and MMD were more common 
in females. Having SLE was associated with poor outcome. 
According to our results, the initial NIHSS scores did not 
differ between patients with and without SLE (median=2 vs. 
2, IQR=1–6 vs. 0–4; p=0.393). However, SLE was associated 
with poor functional outcome at 3 months after stroke on-
set. We can therefore speculate that cerebrovascular inflam-
mation due to autoantibodies leads to poor recovery after IS. 
In addition, inflammation may damage diverse other organs 
such as the kidneys, lungs, and heart, and lead to poor stroke 
outcome.16 In contrast to our results, there are previous re-
ports of outcomes being similar in patients with and without 
SLE after stroke onset.17 However, those studies had retro-
spective designs, included all age groups, and had low pro-
portions of patients with SLE (0.2–0.3%). Our study included 
only young adult patients, and had a much higher propor-
tion of SLE patients (4.1%). Although SLE itself could not 
be an independent risk factor for IS, we believe that having 
SLE may be a poor prognostic factor for IS in young patients, 
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and so more careful management may be called for.
We found that a higher initial glucose level was indepen-
dently associated with poor outcome. This is consistent with 
previous studies showing an association between hypergly-
cemia on admission and a worse clinical outcome of IS.18,19 
The release of catecholamine and inflammatory cytokines 
Table 2. Baseline characteristics of patients with favorable and unfavorable outcomes at 3 months
mRS score=0 or 1 at 3 months
p
Yes (n=213) No (n=57)
Demographics
Age, years 37.2±6.3 36.8±6.3 0.636
Sex, male 146 (69) 37 (65) 0.602*
Risk factor
Hypertension 60 (28) 21 (37) 0.204*
Diabetes mellitus 24 (11) 9 (16) 0.355*
Dyslipidemia 37 (17) 10 (18) 0.976*
Current smoking 99 (47) 30 (53) 0.409*
Atrial fibrillation 4 (2) 2 (4) 0.610‡
Coronary heart disease 4 (2) 0 (0) 0.582‡
PFO 22 (10) 1 (2) 0.059‡
Chronic kidney disease 7 (3) 4 (7) 0.252‡
Body mass index, kg/m2 25.5±4.8 25.4±5.7 0.899
Clinical findings
Initial NIHSS score 1 (0–3) 4 (2–8) <0.001†
Initial SBP, mm Hg 147.2±32.7 150.5±27.3 0.484
Initial DBP, mm Hg 88.2±19.9 91.0±19.3 0.339
Other etiologies
Dissection 31 (15) 7 (13) 0.661*
SLE 6 (3) 5 (9) 0.043*
APS without SLE 7 (3) 1 (2) 1.000‡
Cerebral venous thrombosis 6 (3) 0 (0) 0.348‡
RCVS 2 (1) 2 (4) 0.197‡
Laboratory findings
White-blood-cell count, 103/mm3 8.5±2.8 9.5±3.1 0.030
Hemoglobin, g/dL 14.7±2.0 14.3±2.0 0.191
Blood urea nitrogen, mg/dL 13.4±5.8 15.4±10.8 0.196
Creatinine, mg/dL 0.9±1.0 0.9±0.8 0.881
Total cholesterol, mg/dL 188.3±45.4 185.7±63.9 0.727
Low-density lipoprotein, mg/dL 115.8±38.8 110.6±40.6 0.373
Glucose, mg/dL 118.7±44.3 133.0±73.1 0.187
Hemoglobin A1c, % 5.9±1.5 6.1±1.6 0.335
C-reactive protein, mg/dL 1.1±2.5 2.0±5.3 0.208
Erythrocyte sedimentation rate, mm/hour 14.5±18.1 16.8±19.4 0.387
Homocysteine, mmol/L 10.3±5.7 10.7±6.7 0.709
Fibrinogen, mg/dL 323.0±101.1 355.2±153.7 0.069
Thyroid-stimulating hormone, mIU/mL 2.2±5.7 2.5±8.2 0.814
Acute management
IVT only 6 (2.8) 3 (5.3) 0.290‡
IAT with/without IVT 11 (5.2) 4 (7.0) 0.393‡
Data are mean±SD, median (interquartile range), or n (%) values. Student’s t-test was used except where indicated otherwise.
*Pearson’s chi-square test, †Mann-Whitney U test, ‡Fisher’s exact test.
APS: antiphospholipid syndrome, DBP: diastolic blood pressure, IAT: intra-arterial thrombectomy, IVT: intravenous thrombolysis, mRS: modified Rankin
scale, NIHSS: National Institutes of Health Stroke Scale, PFO: patent foramen ovale, RCVS: reversible cerebral vasoconstriction syndrome, SBP: systolic
blood pressure, SLE: systemic lupus erythematosus.
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after IS might increase the glucose level,18 and an elevated glu-
cose level can exacerbate ischemic brain injury by enhancing 
edema, diminishing vascular reactivity, promoting disrup-
tion of the blood–brain barrier, and provoking lactic acidosis 
and the production of free radicals.18,19 
Previous Korean studies had a male preponderance, as in 
our study.20,21 Higher prevalence rates of hypertension and 
smoking and a higher BMI in males seem to be the reasons for 
this difference. A previous multicenter study of IS in young 
Korean adults (aged between 15 and 45 years) from 2007 to 
2010 found hypertension in 18.0%, DM in 7.8%, and dyslip-
idemia in 2.6% of the enrolled patients. Since the diagnostic 
criteria for risk factors were not described in detail in that 
report, direct comparisons might not be justified. However, 
most of the risk factors including HTN, DM, dyslipidemia, 
and BMI (mean: 24.1 kg/m2→25.5 kg/m2) appear to have in-
creased in frequency.20 In our study, the rates of traditional 
risk factors were increasing but the awareness and treatment 
rates were relatively low, which might increase the incidence 
of stroke. Sustained efforts are required to improve the aware-
ness and treatment of traditional vascular risk factors.
This study was subject to some limitations. First, we enrolled 
patients from a single ethnic group (Korean) and observed 
them for only 3 months. However, the study data might be 
applicable at least to all Asians, and ongoing follow-up may 
provide further significant results. Second, we only included 
IS patients. However, information about this single group is 
also meaningful. Third, mostly metropolitan centers were in-
cluded in this study, and lifestyle and risk factors may differ 
between rural and urban areas. However, young adults tend to 
live in cities and we believe that the data for the total popula-
tion of young patients would not differ greatly.22 Fourth, since 
SLE was diagnosed in only 4.1% of the participants and this 
condition is accompanied by many systemic problems, cau-
tion is needed when interpreting the results. Finally, exclud-
ing patients with recurrent stroke and those admitted to de-
partments other than neurology due to a need for surgery or 
the presence of severe trauma may have been responsible for 
the relatively good prognoses in our study.
In conclusion, the findings of this study emphasize the im-
portance of improving the awareness and prevention of tra-
ditional vascular risk factors for IS in young adults, including 
Table 3. Results of multivariable logistic regression analysis of potential factors for an unfavorable outcome
Unadjusted OR Adjusted OR p
Initial NIHSS score 1.225 (1.135–1.321) 1.209 (1.115–1.311) <0.001
PFO 0.155 (0.020–1.176) 0.180 (0.017–1.924) 0.156
SLE 3.317 (0.974–11.294) 4.633 (1.068–20.101) 0.041
RCVS 3.836 (0.528–27.850) 4.545 (0.483–42.798) 0.186
White-blood-cell count, per 103/mm3 increase 1.109 (1.009–1.220) 1.082 (0.959–1.221) 0.205
Blood urea nitrogen, per 1 mg/dL increase 1.032 (0.996–1.070) 1.032 (0.990–1.075) 0.141
Glucose, per 1 mg/dL increase 1.005 (0.999–1.010) 1.006 (1.000–1.012) 0.049
Fibrinogen, per 1 mg/dL increase 1.002 (1.000–1.005) 1.000 (0.997–1.003) 0.941
p values are for the multivariate model. Data are OR (95% confidence interval) values. Adjusted for covariates for which p<0.2 in the univariate anal-
ysis (NIHSS score, PFO, SLE, RCVS, white-blood-cell count, blood urea nitrogen, fasting glucose, and fibrinogen).  
NIHSS: National Institute of Health Stroke Scale, OR: odds ratio, PFO: patent foramen ovale, RCVS: reversible cerebral vasoconstriction syndrome SLE: 
systemic lupus erythematosus.
0                10 20              30             40    50 60               70               80               90               100
Patients (%)
Score on the mRS
0 1 2 3 4 5 6 
33.7 37 20      4.1   4.4
45.2 33.7  11.5          4.4    3.7
At discharge
At 3 months
Fig. 1. mRS scores at discharge and after 3 months. The mRS scores range from 0 to 6: 0, no symptoms; 1, no clinically significant disability; 2, 
slight disability; 3, moderate disability; 4, moderately severe disability; 5, severe disability; and 6, death. About 90% of patients had a good out-
come (mRS score ≤2) at 3 months after stroke onset. mRS: modified Rankin Scale.
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hypertension, DM, dyslipidemia, smoking, and obesity. Al-
though the outcomes tended to be favorable with a good re-
sponse to thrombolysis, SLE was associated with poor func-
tional outcome.
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